Pfizer’s atopic dermatitis treatment meets goals in late-stage study

95

Pfizer Inc’s new atopic dermatitis treatment met the main goals in a late-stage study that tested the drug in patients aged 12 and older with moderate to severe forms of the disease, the drugmaker said on Wednesday.

http://feeds.reuters.com/~r/reuters/healthNews/~3/Ra9tXw12S-w/pfizers-atopic-dermatitis-treatment-meets-goals-in-late-stage-study-idUSKCN1SL17R

- Advertisement -